News

Researchers describe a novel device that utilizes immunosensor and bio-optical technology to detect M. tuberculosis antigen (Ag85B) in cough and demonstrate its use under field conditions during a pilot study in an area of high TB incidence.

Unilife Corporation has launched Unitract.com to support the commercial release of its Unitract 1 mL clinical safety syringes.

Researchers show that public education campaigns regarding hand hygiene are effective in altering individual hand hygiene habits during the peak periods of influenza transmission.

When Staphylococcus aureus is isolated in urine, it is thought to usually represent hematogenous spread. Because such spread might have special clinical significance, Shingo Chihara and colleagues evaluated predictors and outcomes of S. aureus bacteriuria among patients with S. aureus bacteremia.

Researchers have discovered a novel mechanism in Salmonella that affects its virulence and its susceptibility to antibiotics by changing its production of proteins in a previously unheard of manner. This allows Salmonella to selectively change its levels of certain proteins to respond to inhospitable conditions.

A new research consortium through which to address persistent knowledge gaps could be precisely what the healthcare epidemiology and infection prevention community has been waiting for in light of urgent scientific and clinical questions requiring more definitive answers

The Natural Resources Defense Council (NRDC) says it has filed a lawsuit against the Food and Drug Administration (FDA) for failing to issue a final rule regulating the chemicals triclosan and triclocarban, which are commonly found in antibacterial soaps.

Thermo Fisher Scientific Inc. announces today that it has received Food and Drug Administration (FDA) clearance for Spectra VRE, a test designed to screen for vancomycin-resistant Enterococcus (VRE).

Media reports of outbreaks and infections caused by unsafe injection practices in healthcare facilities especially in outpatient settings seem to confirm the Centers for Disease Control and Prevention (CDC) statistics that since 1999, more than 125,000 U.S. patients have received letters alerting them of potential exposure to infection with hepatitis viruses or human immunodeficiency virus (HIV) due to unsafe injection practices such as the reuse of syringes.

ICT turned to members of industry to determine what they believe is the single most important thing that clinicians can do to prevent needlesticks, sharps injuries and other percutaneous injuries. They also share how their technology helps prevent these types of injuries.